ArticleCardiovascular diabetology2023

Sodium-glucose co-transporter 2 inhibitor use in patients with diabetes mellitus undergoing endovascular therapy for symptomatic peripheral artery disease.

Mitsuyoshi Takahara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.